Ingenol ameliorates silicosis via targeting the PTGS2/PI3K/AKT signaling axis: Implications for therapeutic intervention
- 31 March 2025
- journal article
- Published by Elsevier in Cellular Signalling
- Vol. 131, 111780
Abstract
No abstract availableKeywords
Funding Information
- Anhui University of Science and Technology (QNZD202203)
- Natural Science Foundation of Anhui Province (2408085QH236)
- National Natural Science Foundation of China (82404727)
This publication has 45 references indexed in Scilit:
- 13-Oxyingenol-dodecanoate inhibits the growth of non-small cell lung cancer cells by targeting ULK1Bioorganic Chemistry, 2024
- Mefloquine improves pulmonary fibrosis by inhibiting the KCNH2/Jak2/Stat3 signaling pathway in macrophagesBiomedicine & Pharmacotherapy, 2024
- The NLRP3 inflammasome: a vital player in inflammation and mediating the anti-inflammatory effect of CBDInflammation Research, 2024
- Soluble E‐cadherin participates in BLM‐induced pulmonary fibrosis by promoting EMT and lung fibroblast migrationEnvironmental Toxicology, 2023
- Recent development on COX-2 inhibitors as promising anti-inflammatory agents: The past 10 yearsActa Pharmaceutica Sinica B, 2022
- Presegetane diterpenoids from Euphorbia sieboldiana as a new type of anti-liver fibrosis agents that inhibit TGF-β/Smad signaling pathwayBioorganic Chemistry, 2021
- Ginsenoside metabolite compound K exerts anti-inflammatory and analgesic effects via downregulating COX2Inflammopharmacology, 2018
- F4/80 as a Major Macrophage Marker: The Case of the Peritoneum and Spleen2017
- Inhibiting PI3K-AKt signaling pathway is involved in antitumor effects of ginsenoside Rg3 in lung cancer cellBiomedicine & Pharmacotherapy, 2017
- The role of α-smooth muscle actin in fibroblast-mediated matrix contraction and remodelingBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2017